|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/69 | (2017.01) |
| A61K 38/07 | (2006.01) | ||
| B82Y 5/00 | (2011.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2662094 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13167148.9 |
| Date of filing the European patent application | 2013-05-08 | |
| (97) | Date of publication of the European application | 2013-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-17 |
| (46) | Date of publication of the claims translation | 2024-07-10 |
| (30) | Number | Date | Country code |
| 201261644122 P | 2012-05-08 | US | |
| 201361777475 P | 2013-03-12 | US |
| (72) |
Lewis, Evan , US
Shwonek, Peter , US
Dalziel, Sean , US
Jumaa, Mouhannad , US
|
| (73) |
Onyx Therapeutics, Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ciklodekstrino kompleksodaros metodai, skirti peptidų proteasomos komponavimui |
| Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 13 | 289.00 EUR |
| 2026-05-08 |